-
Patients with a first VTE event occurring in association with a reversible or time-limited risk factor should be treated with anticoagulants for at least three months, whereas patients with a first PE should be treated for at least six to 12 months; in fact, a case can be made for indefinite anticoagulant therapy in PE patients who have a great concern about recurrent PE and/or who are minimally concerned about the bleeding risk of anticoagulant therapy and the need for frequent determinations of the INR.
-
Female physicians have more than twice the rate of suicide as other professional women and are proportionally at greater risk compared with their male physician counterparts.
-
-
Two-part series on complications of pregnancy.
-
This single-center, retrospective study examined ICU mortality and various risk factors among critically ill patients who developed bacteremia during their VAP episode.
-
Use of specially trained palliative care teams in the ICU has increased in frequency in recent years. Consultation by these teams tends to occur very late in patients' length of stay. Few studies have been performed evaluating outcomes, such as length of stay.
-
Invasive aspergillosis (IA) is increasingly recognized as a source of infection in immunocompromised ICU patients, but accurate diagnosis remains challenging.
-
In the majority of patients who develop the acute respiratory distress syndrome (ARDS), oxygenation can be supported using increased inspired oxygen concentrations (FIO2) or higher levels of positive end-expiratory pressure (PEEP).
-
Prilosec and Nexium Cleared; Anastrozole over Tamoxifen for Breast Cancer; Antibiotics and Steroids Not for Sinusitis; FDA Actions
-
